Physician
Providence Facey Medical Foundation
Providence Facey Medical Foundation was paid $2.19M by Medicaid between Jan 2018 and Nov 2024, across 82 billing codes. Its largest line is 99233, hospital visit by a doctor, follow-up day (complex) — 23% of everything it billed.
33Billing provider infoPROVIDENCE FACEY MEDICAL FOUNDATION
VALENCIA, CA 91355
VALENCIA, CA 91355
33aNPI1710031588assigned 01/22/2007
33bProvider typeOtolaryngology Physician
28Total paid$2.19M
24GClaims137,399
24DCodes billed82
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Otolaryngology Physician providers in California
Rank by total paid#8 of 168
Median peer was paid$67K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,938 | $180K | |
| 2019 | 28,321 | $415K | |
| 2020 | 17,400 | $283K | |
| 2021 | 10,304 | $237K | |
| 2022 | 8,909 | $173K | |
| 2023 | 28,336 | $486K | |
| 2024incomplete | 29,191 | $421K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 23% | 15,630 | 4,774 | $499K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 20,325 | 18,881 | $451K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 35,281 | 33,090 | $432K |
| 99223 | Prolong inpt eval add15 m | 11% | 4,269 | 4,029 | $242K |
| 99239 | Hospital discharge day management, more than 30 minutes | 6.0% | 3,691 | 3,511 | $131K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 1,431 | 1,350 | $73K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.3% | 1,938 | 743 | $51K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 3,156 | 3,150 | $37K |
| 90686 | 1.3% | 4,680 | 4,675 | $27K | |
| 90670 | 1.0% | 1,010 | 1,010 | $22K | |
| 99335 | <1% | 1,083 | 1,046 | $21K | |
| G9920 | Screening performed and negative | <1% | 5,128 | 5,107 | $18K |
70 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,986 | $16K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 314 | $15K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 423 | $15K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 954 | $14K |
| 99336 | <1% | 395 | $13K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 473 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 333 | $10K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 179 | $8K |
| 99220 | <1% | 84 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 213 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,430 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 351 | $6K |
| 99306 | Prolong nursin fac eval 15m | <1% | 104 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 952 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 657 | $5K |
| Z1034 | <1% | 87 | $5K | |
| 99285 | Emergency room visit (most serious) | <1% | 14 | $5K |
| 92551 | <1% | 3,481 | $4K | |
| 90656 | <1% | 374 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 117 | $2K |
| 99348 | <1% | 63 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 463 | $2K |
| 90480 | <1% | 40 | $2K | |
| 99217 | <1% | 49 | $2K | |
| 93000 | <1% | 247 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,486 | $1K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 104 | $1K |
| 90697 | <1% | 36 | $1K | |
| 59025 | Fetal non-stress test | <1% | 115 | $919.56 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 625 | $900.00 |
| 90698 | <1% | 231 | $869.40 | |
| 99442 | <1% | 14 | $810.97 | |
| 90633 | <1% | 119 | $716.66 | |
| 90677 | <1% | 100 | $675.00 | |
| 90680 | <1% | 160 | $598.99 | |
| 20610 | <1% | 152 | $594.49 | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 55 | $591.39 |
| 90651 | <1% | 28 | $555.64 | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 12 | $532.90 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 693 | $465.72 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $364.56 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 625 | $325.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 241 | $240.39 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,508 | $220.95 |
| 90734 | <1% | 30 | $160.91 | |
| 99334 | <1% | 36 | $157.82 | |
| G0008 | Administration of influenza virus vaccine | <1% | 170 | $151.00 |
| 85018 | <1% | 884 | $150.98 | |
| 90744 | <1% | 39 | $123.75 | |
| 96127 | <1% | 241 | $115.80 | |
| 90682 | <1% | 69 | $89.60 | |
| 90688 | <1% | 38 | $89.20 | |
| 92015 | Determination of refractive state | <1% | 15 | $87.23 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 23 | $76.72 |
| 11721 | <1% | 564 | $59.64 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,039 | $55.17 |
| 90672 | <1% | 40 | $42.75 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12 | $18.65 |
| 81003 | <1% | 104 | $8.95 | |
| 99173 | <1% | 2,508 | $3.99 | |
| 1220F | 0% | 100 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 238 | $0.00 |
| 1125F | 0% | 43 | $0.00 | |
| 1159F | 0% | 3,566 | $0.00 | |
| 1160F | 0% | 1,695 | $0.00 | |
| 90461 | 0% | 1,118 | $0.00 | |
| 90653 | 0% | 65 | $0.00 | |
| 92552 | 0% | 14 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 12 | $0.00 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.